You must have JavaScript enabled to view certain links and/or sign up for the Succeed Newsletter.
Grants.Gov

   Home  > Find Grant Opportunities > Search Grant Opportunities > Search Results > Synopsis

Evaluation of Treatments and Services Provided to People with Duchenne Muscular Dystrophy (DMD)

Department of Health and Human Services

 
Synopsis
       


The synopsis for this grant opportunity is detailed below, following this paragraph. This synopsis contains all of the updates to this document that have been posted as of 12/11/2012 . If updates have been made to the opportunity synopsis, update information is provided below the synopsis.

If you would like to receive notifications of changes to the grant opportunity click send me change notification emails . The only thing you need to provide for this service is your email address. No other information is requested.

Any inconsistency between the original printed document and the disk or electronic document shall be resolved by giving precedence to the printed document.

Document Type: Grants Notice
Funding Opportunity Number: RFA-DD-13-002
Opportunity Category: Discretionary
Posted Date: Dec 11, 2012
Creation Date: Dec 11, 2012
Original Closing Date for Applications: Feb 20, 2013    Letter of Intent Due Date: January 23, 2013 Application Due Date: February 20, 2013 by 5:00 PM U.S. Eastern Time
Current Closing Date for Applications: Feb 20, 2013    Letter of Intent Due Date: January 23, 2013 Application Due Date: February 20, 2013 by 5:00 PM U.S. Eastern Time
Archive Date: Mar 22, 2013
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Estimated Total Program Funding: $550,000
Award Ceiling: $150,000
Award Floor: $0
CFDA Number(s): 93.283  --  The Affordable Care Act: Centers for Disease Control and Prevention_Investigations and Technical Assistance
Cost Sharing or Matching Requirement: No

Eligible Applicants

Others (see text field entitled "Additional Information on Eligibility" for clarification)
 

Additional Information on Eligibility:

1. Eligible Applicants Eligible Organizations Higher Education Institutions: • Public/State Controlled Institutions of Higher Education • Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: • Hispanic-serving Institutions • Historically Black Colleges and Universities (HBCUs) • Tribally Controlled Colleges and Universities (TCCUs) • Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education • Nonprofits (Other than Institutions of Higher Education) For- Profit Organizations • Small Businesses • For-Profit Organizations (Other than Small Businesses) Governments • State Governments • County Governments • City or Township Governments • Special District Governments • Indian/Native American Tribal Governments (Federally Recognized) • Indian/Native American Tribal Governments (Other than Federally Recognized) • Eligible Agencies of the Federal Government • U.S. Territory or Possession Other • Independent School Districts • Public Housing Authorities/Indian Housing Authorities • Native American tribal organizations (other than Federally recognized tribal governments) • Faith-based or Community-based Organizations • Regional Organizations • Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov. 2. Foreign Organizations Foreign Organizations are not eligible to apply. Foreign components of U.S. Organizations are not eligible to apply.

Agency Name

Centers for Disease Control and Prevention

Description

The purpose of this project is to systematically evaluate agreement between treatments and services actually provided to people who have Duchenne muscular dystrophy (DMD) and current treatment recommendations as documented in the DMD Care Considerations. The evaluation will focus on a limited geographic area (such as one or more states) but the design and results of the study should apply to other geographic areas.

Link to Additional Information

THIS IS NOT AN ACTIVE LINK. PLEASE CLICK ON THE WORDS "FULL ANNOUNCEMENT" AT THE TOP OF THIS PAGE

If you have difficulty accessing the full announcement electronically, please contact:

CDC
Procurement and Grants Office
TIMS
Phone 770-488-2700 PGOTIM@cdc.gov

Synopsis Modification History

There are currently no modifications for this opportunity.